Evidence map›Paper›PMID 33483222›Full record

ArticleJournal of substance abuse treatment2021

Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).

Elizabeth A Evans, Thomas J Stopka, Ekaterina Pivovarova, Sean M Murphy, Faye S Taxman, Warren J Ferguson, Dana Bernson, Claudia Santelices, Kathryn E McCollister, Randall Hoskinson and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Use of Big Data and Ethical Issues for Populations With Substance Use Disorder.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2023
    Article
  16. Article
  17. Stakeholder-engaged research is necessary across the criminal-legal spectrum.Journal of clinical and translational science · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Elizabeth A EvansDepartment of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, 312 Arnold House, 715 North Pleasant Street, Amherst, MA 01003, United States of America. Electronic address: eaevans@umass.edu.
Thomas J StopkaDepartment of Public Health and Community Medicine, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, United States of America.
Ekaterina PivovarovaDepartment of Psychiatry, University of Massachusetts Medical School and Massachusetts Center of Excellence for Specialty Courts, Worcester, MA, United States of America; Department of Family Medicine and Community Health, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, United States of America.
Sean M MurphyDepartment of Population Health Sciences, Weill Cornell Medical College, 425 East 61st Street, Suite 301, New York, NY, United States of America. Electronic address: smm2010@med.cornell.edu.
Faye S TaxmanCenter for Advancing Correctional Excellence, George Mason University, 4087 University Drive, 4100, MSN6D3, Fairfax, VA 22030, United States of America.
Warren J FergusonDepartment of Family Medicine and Community Health, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, United States of America. Electronic address: warren.ferguson@umassmemorial.org.
Dana BernsonMassachusetts Department of Public Health, 250 Washington Street, Boston, MA 02108, United States of America.
Claudia SantelicesUrban Health Research and Practice, Northeastern University, Boston, MA, United States of America.
Kathryn E McCollisterSoffer Clinical Research Center, Department of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14(th) Street, Suite 1019, Miami, FL 33136, United States of America. Electronic address: kmccolli@miami.edu.
Randall HoskinsonUniversity of Massachusetts Medical School - Baystate, Springfield, MA, United States of America.
Thomas LincolnUniversity of Massachusetts Medical School - Baystate, Springfield, MA, United States of America.
Peter D FriedmannUniversity of Massachusetts Medical School - Baystate, Springfield, MA, United States of America. Electronic address: peter.friedmannmd@baystatehealth.org.
MassJCOIN Research Group
Baystate Medical Center · USUniversity of Massachusetts Chan Medical School · USMassachusetts Department of Public Health · USCornell University · USGeorge Mason University · USNortheastern University · USTufts University · USUniversity of Massachusetts Amherst · USUniversity of Miami · US

Funding

Massachusetts Justice Cooperative Opioid Innovation Network (JCOIN) Research CenterUG1DA050067 · NIDA · UNIVERSITY OF MASSACHUSETTS AMHERST · PI EVANS, ELIZABETH A., FRIEDMANN, PETER D · 2019 to 2023
$10.5M
Increasing Referrals to Medications for Opioid Use Disorders from Drug Treatment Courts using Organizational Linkage InterventionK23DA049953 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PIVOVAROVA, EKATERINA · 2020 to 2022
$612k
NIDA NIH HHS K23 DA049953NIDA NIH HHS UG1 DA050067
6 · The paper itself

Abstract

A major driver of the U.S. opioid crisis is limited access to effective medications for opioid use disorder (MOUD) that reduce overdose risks. Traditionally, jails and prisons in the U.S. have not initiated or maintained MOUD for incarcerated individuals with OUD prior to their return to the community, which places them at high risk for fatal overdose. A 2018 law (Chapter 208) made Massachusetts (MA) the first state to mandate that five county jails deliver all FDA-approved MOUDs (naltrexone [NTX], buprenorphine [BUP], and methadone). Chapter 208 established a 4-year pilot program to expand access to all FDA-approved forms of MOUD at five jails, with two more MA jails voluntarily joining this initiative. The law stipulates that MOUD be continued for individuals receiving it prior to detention and be initiated prior to release among sentenced individuals where appropriate. The jails must also facilitate continuation of MOUD in the community on release. The Massachusetts Justice Community Opioid Innovation Network (MassJCOIN) partnered with these seven diverse jails, the MA Department of Public Health, and community treatment providers to conduct a Type 1 hybrid effectiveness-implementation study of Chapter 208. We will: (1) Perform a longitudinal treatment outcome study among incarcerated individuals with OUD who receive NTX, BUP, methadone, or no MOUD in jail to examine postrelease MOUD initiation, engagement, and retention, as well as fatal and nonfatal opioid overdose and recidivism; (2) Conduct an implementation study to understand systemic and contextual factors that facilitate and impede delivery of MOUDs in jail and community care coordination, and strategies that optimize MOUD delivery in jail and for coordinating care with community partners; (3) Calculate the cost to the correctional system of implementing MOUD in jail, and conduct an economic evaluation from state policy-maker and societal perspectives to compare the value of MOUD prior to release from jail to no MOUD among matched controls. MassJCOIN made significant progress during its first six months until the COVID-19 pandemic began in March 2020. Participating jail sites restricted access for nonessential personnel, established other COVID-19 mitigation policies, and modified MOUD programming. MassJCOIN adapted research activities to this new reality in an effort to document and account for the impacts of COVID-19 in relation to each aim. The goal remains to produce findings with direct implications for policy and practice for OUD in criminal justice settings.

Indexed as

BuprenorphineCOVID-19Opioid-Related DisordersAnalgesics, OpioidHumansMassachusettsOpiate Substitution TreatmentPandemicsSARS-CoV-2Analgesics, OpioidBuprenorphineBuprenorphineCriminal justice settingsMassachusetts Justice Community Opioid Innovation Network (MassJCOIN)Medications for opioid use disorderMethadoneMOUDNaltrexoneOpioid use disorderResearch protocol

Identifiers

PMID33483222
PMCPMC8263807
OpenAlexW3120451252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.